HORNBACH Baumarkt AG

  • WKN: 608440
  • ISIN: DE0006084403
  • Land: Deutschland

Nachricht vom 01.10.2021 | 09:18

HORNBACH Baumarkt AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

HORNBACH Baumarkt AG / Preliminary announcement on the disclosure of financial statements
01.10.2021 / 09:18
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

HORNBACH Baumarkt AG hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 1st half-year

Language: German
Date of disclosure: June 29, 2022
Address: https://www.hornbach-holding.de/de/mediacenter/mediacenter.html#publikationen

Language: English
Date of disclosure: June 29, 2022
Address: https://www.hornbach-holding.de/en/mediacenter/mediacenter.html#publications

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: December 22, 2022
Address: https://www.hornbach-holding.de/de/mediacenter/mediacenter.html#publikationen

Language: English
Date of disclosure: December 22, 2022
Address: https://www.hornbach-holding.de/en/mediacenter/mediacenter.html#publications


01.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021